人类葡萄糖促进剂抑制的基础分子机制
1The Sichuan Provincial Key Laboratory for Human Disease Gene Study, The Department of Medical Genetics, The Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China; Research Unit for Blindness Prevention, Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, P.R. China.
葡萄糖运输体 (GLUT) 对细胞能量至关重要,并与糖尿病和癌症等疾病有关. 结构研究揭示了GLUT机制,有助于开发针对GLUT的新型癌症疗法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 葡萄糖载体 (GLUT) 对于细胞代谢和葡萄糖平衡至关重要.
- GLUT功能障碍与包括糖尿病和GLUT1缺陷综合征在内的疾病有关.
- 升高的GLUT表达驱动癌症中的华堡效应,将GLUT作为治疗点.
研究的目的:
- 总结关于人类GLUTs及其在癌症中的作用的当前知识.
- 为了突出GLUT结构特征的最新进展.
- 为了比较GLUT抑制剂的治疗优化机制.
主要方法:
- 对GLUT和同类蛋白质蛋白质数据库 (PDB) 结构的审查.
- 对基质识别和运输的分子机制的分析.
- 对外面和内面GLUT抑制剂作用的比较.
主要成果:
- 30GLUT和同类结构显示出不同的形状和带结合状态.
- 结构数据阐明了GLUT基质识别,运输周期和抑制.
- 了解GLUT抑制机制为治疗设计提供了信息.
结论:
- 人类GLUT在癌症中通过华堡效应至关重要.
- 对GLUT的结构洞察力有助于开发有针对性的抗瘤疗法.
- 对GLUT抑制剂的比较分析有助于优化癌症治疗药物设计.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Biguanides and Glitazones
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...


